[Daptomycin for the treatment of gram-positive infections after cardiac surgery]
Related Experiment Videos
1Klinik für Anaesthesiologie, Klinikum der Universität München-Campus Großhadern, Munich, Germany.
Background And Method:
Surgical infection remains a main cause of death after heart surgery, despite advances in pharmacological therapy. Daptomycin is a cyclic lipopeptide antibiotic, useful in gram-positive organisms resistant to standard treatment, including vancomycin. The aim of this study was to describe the use of daptomycin regarding efficacy, efficiency and safety in patients with gram-positive infections after heart surgery using a retrospective analysis on 49 adult patients.
Conclusion:
Daptomycin shows excellent in vitro and in vivo activity against gram-positive organisms, such as Enterococcus faecalis, Enterococcus faecium, Staphylococcus aureus, especially MRSA. Daptomycin is also effective against increasing vancomycin-resistant or vancomycin-intermediate S. aureus.
Insights
Daptomycin effectively treats gram-positive infections in heart surgery patients. This antibiotic shows good efficacy and safety for challenging infections, including those resistant to vancomycin.
Area of Science:
- Infectious Diseases
- Pharmacology
- Cardiovascular Surgery
Context:
- Surgical site infections are a significant cause of mortality following cardiac surgery.
- Gram-positive bacteria, including vancomycin-resistant strains, pose a therapeutic challenge.
- Daptomycin is a lipopeptide antibiotic with activity against gram-positive pathogens.
Purpose:
- To evaluate the efficacy, efficiency, and safety of daptomycin in adult patients with gram-positive infections post-cardiac surgery.
- To describe the clinical utility of daptomycin in a real-world setting for this patient population.
Summary:
- A retrospective analysis of 49 adult patients undergoing heart surgery with gram-positive infections treated with daptomycin was conducted.
- Daptomycin demonstrated effective in vitro and in vivo activity against key gram-positive organisms like Enterococcus faecalis, Enterococcus faecium, and Staphylococcus aureus (including MRSA).
- The antibiotic was effective in treating infections caused by vancomycin-resistant or vancomycin-intermediate Staphylococcus aureus.
Impact:
- Daptomycin represents a viable therapeutic option for managing complex gram-positive infections in post-cardiac surgery patients.
- Findings support the use of daptomycin in cases of antibiotic resistance, improving patient outcomes.
- This study contributes to understanding daptomycin's role in combating surgical infections in cardiovascular surgery.
Related Concept Videos
Endocarditis III: Medical Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis IV: Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Heart Failure Drugs: Inotropic Agents
Myocarditis III: Medical Management